down arrow

Sun Pharma.Inds.

Part of MojoOne Strategy
  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE044A01036
  • NSEID: SUNPHARMA
  • BSEID: 524715
INR
1,804.05
-14.55 (-0.8%)
BSENSE

Dec 05

BSE+NSE Vol: 12.7 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Sep'25
Sep'24
Dec'23
Sep'23
Sep'22
Sep'21
Sep'20
Net Sales
28,329.71
25,944.14
36,513.95
24,133.25
21,714.04
19,344.67
16,138.38
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
28,329.71
25,944.14
36,513.95
24,133.25
21,714.04
19,344.67
16,138.38
Raw Material Cost
3,393.10
3,195.73
5,227.60
3,517.94
4,017.94
3,147.04
2,978.72
Purchase of Finished goods
2,135.77
1,872.53
2,483.27
1,686.78
1,791.88
1,836.72
1,565.01
(Increase) / Decrease In Stocks
268.62
301.37
571.33
340.54
-201.55
187.53
-427.80
Employee Cost
5,566.45
4,932.32
7,129.72
4,766.40
4,079.41
3,565.01
3,464.33
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
1,008.20
0.00
0.00
Other Expenses
8,137.06
8,095.61
11,114.05
7,310.44
5,177.22
5,157.35
4,521.33
Total Expenditure (Excl Depreciation)
19,501.00
18,397.56
26,525.97
17,622.10
15,873.10
13,893.65
12,101.59
Operating Profit (PBDIT) excl Other Income
8,828.71
7,546.58
9,987.98
6,511.15
5,840.94
5,451.02
4,036.79
Other Income
934.38
886.55
748.25
498.05
87.36
375.41
409.57
Operating Profit (PBDIT)
9,763.09
8,433.13
10,736.23
7,009.20
5,928.30
5,826.43
4,446.36
Interest
174.66
130.71
164.90
130.17
33.08
71.04
85.23
Exceptional Items
-818.00
0.00
-392.68
-322.87
0.00
-631.07
-3,633.33
Gross Profit (PBDT)
8,770.43
8,302.42
10,178.65
6,556.16
5,895.22
5,124.32
727.80
Depreciation
1,430.05
1,281.04
1,906.28
1,284.14
1,197.95
1,033.59
994.52
Profit Before Tax
7,340.38
7,021.38
8,272.37
5,272.02
4,697.27
4,090.73
-266.72
Tax
1,900.67
1,119.46
1,290.52
858.20
341.25
593.35
214.71
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
5,439.71
5,901.92
6,981.85
4,413.82
4,356.02
3,497.38
-481.43
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
5,439.71
5,901.92
6,981.85
4,413.82
4,356.02
3,497.38
-481.43
Share in Profit of Associates
-21.89
-4.08
-30.56
-23.07
-6.73
-7.00
-2.04
Minority Interest
-21.24
-22.06
-29.49
7.30
-26.19
0.80
640.66
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
5,396.58
5,875.78
6,921.80
4,398.05
4,323.10
3,491.18
157.19
Equity Capital
239.93
239.93
239.93
239.93
239.93
239.93
239.93
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
49,296.32
0.00
Earnings per share (EPS)
22.49
24.49
28.85
18.33
18.02
14.55
0.66
Diluted Earnings per share
22.5
24.5
28.8
18.3
18.0
14.5
0.66
Operating Profit Margin (Excl OI)
31.32%
29.26%
27.79%
27.37%
27.23%
28.35%
25.35%
Gross Profit Margin
31.11%
32.19%
28.32%
27.56%
27.48%
26.65%
4.57%
PAT Margin
19.3%
22.89%
19.42%
18.55%
20.3%
18.19%
-3.02%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is 9.20%

stock-summary

Consolidate Net Profit

Growth in half year ended Sep 2025 is -8.16%

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is 16.99%

stock-summary

Interest

Growth in half year ended Sep 2025 is 33.62%

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has improved from Sep 2024

Compare Half Yearly Results Of Sun Pharma.Inds. With
Markets Mojo
Figures in Cr
Consolidate Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
28,329.71
5,125.00
23,204.71
452.77%
Other Operating Income
0.00
0.00
0.00
Total Operating income
28,329.71
5,125.00
23,204.71
452.77%
Raw Material Cost
3,393.10
1,947.00
1,446.10
74.27%
Purchase of Finished goods
2,135.77
0.00
2,135.77
(Increase) / Decrease In Stocks
268.62
82.00
186.62
227.59%
Employee Cost
5,566.45
694.00
4,872.45
702.08%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
8,137.06
785.00
7,352.06
936.57%
Total Expenditure (Excl Depreciation)
19,501.00
3,508.00
15,993.00
455.90%
Operating Profit (PBDIT) excl Other Income
8,828.71
1,617.00
7,211.71
445.99%
Other Income
934.38
264.00
670.38
253.93%
Operating Profit (PBDIT)
9,763.09
1,881.00
7,882.09
419.04%
Interest
174.66
11.00
163.66
1,487.82%
Exceptional Items
-818.00
0.00
-818.00
Gross Profit (PBDT)
8,770.43
1,870.00
6,900.43
369.01%
Depreciation
1,430.05
225.00
1,205.05
535.58%
Profit Before Tax
7,340.38
1,645.00
5,695.38
346.22%
Tax
1,900.67
411.00
1,489.67
362.45%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
5,439.71
1,234.00
4,205.71
340.82%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
5,439.71
1,234.00
4,205.71
340.82%
Share in Profit of Associates
-21.89
0.00
-21.89
Minority Interest
-21.24
0.00
-21.24
Other related items
0.00
0.00
0.00
Consolidated Net Profit
5,396.58
1,234.00
4,162.58
337.32%
Equity Capital
239.93
53.00
186.93
352.70%
Face Value
1.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
22.49
46.57
-24.08
-51.71%
Diluted Earnings per share
22.50
46.46
-23.96
-51.57%
Operating Profit Margin (Excl OI)
31.32%
31.55%
0.00
-0.23%
Gross Profit Margin
31.11%
36.49%
0.00
-5.38%
PAT Margin
19.30%
24.08%
0.00
-4.78%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 28,329.71 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 9.20%

Half Yearly - Consolidate Net Profit
Consolidate Net Profit 5,396.58 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is -8.16%

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 8,828.71 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 16.99%

Half Yearly - Interest
Interest 174.66 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 33.62%

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 31.32%
in Sep 2025

Figures in %
stock-summary

Growth in half year ended Sep 2025 has improved from Sep 2024

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."